Form 4: Privia Health Group Director, Nancy Cocozza, Reports Acquisition of Restricted Stock Units

Director Nancy Cocozza reports acquisition of 11,124 restricted stock units in Privia Health Group, Inc.

Summary

• On May 23, 2024, Nancy Cocozza, a director of Privia Health Group, Inc., filed a Form 4 with the SEC.
• The form reports a transaction on May 22, 2024, where Cocozza acquired 11,124 restricted stock units (RSUs) under the company's 2021 Omnibus Incentive Plan.
• These RSUs will vest on the earlier of the day before the 2025 annual meeting of stockholders or the first anniversary of the grant date.
• Following the reported transaction, Cocozza beneficially owns 25,955 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of RSUs by a director is generally viewed as a positive, but it's not a major event.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is tied to future events (2025 annual meeting or one-year anniversary), suggesting a focus on long-term performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for incentivizing and retaining key personnel.

Stakeholder Impact

• The acquisition of restricted stock units by a director may have a minor positive impact on shareholder sentiment.

Key Dates